| HLAVÁČKOVÁ, Eva, Kateřina PILÁTOVÁ, Lenka FĚDOROVÁ, Peter MÚDRY, Pavel MAZÁNEK, Jaroslav ŠTĚRBA and Lenka ZDRAŽILOVÁ DUBSKÁ. Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine. In Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO). 2019. ISSN 0923-7534. Available from: https://dx.doi.org/10.1093/annonc/mdz448.006. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{1612076,
author = {Hlaváčková, Eva and Pilátová, Kateřina and Fědorová, Lenka and Múdry, Peter and Mazánek, Pavel and Štěrba, Jaroslav and Zdražilová Dubská, Lenka},
booktitle = {Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO)},
doi = {http://dx.doi.org/10.1093/annonc/mdz448.006},
keywords = {monocyte-derived dendritic cell anticancer vaccine},
language = {eng},
title = {Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine},
url = {https://www.annalsofoncology.org/article/S0923-7534(20)34420-3/abstract},
year = {2019}
}
TY - CONF
ID - 1612076
AU - Hlaváčková, Eva - Pilátová, Kateřina - Fědorová, Lenka - Múdry, Peter - Mazánek, Pavel - Štěrba, Jaroslav - Zdražilová Dubská, Lenka
PY - 2019
TI - Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine
KW - monocyte-derived dendritic cell anticancer vaccine
UR - https://www.annalsofoncology.org/article/S0923-7534(20)34420-3/abstract
L2 - https://www.annalsofoncology.org/article/S0923-7534(20)34420-3/abstract
N2 - Refractory and relapsing sarcoma and high-risk neuroblastoma show poor prognoses. Monocyte-derived dendritic cell anticancer vaccine could extend the treatment modalities in these patients. Pharmacotherapy prior to mononuclear cell harvest may influence the quality of manufactured dendritic cell product.
ER -
HLAVÁČKOVÁ, Eva, Kateřina PILÁTOVÁ, Lenka FĚDOROVÁ, Peter MÚDRY, Pavel MAZÁNEK, Jaroslav ŠTĚRBA and Lenka ZDRAŽILOVÁ DUBSKÁ. Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine. In \textit{Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO)}. 2019. ISSN~0923-7534. Available from: https://dx.doi.org/10.1093/annonc/mdz448.006.
|
